Skip Header

 
Contribute Send feedback

Reviewed, UniProtKB/Swiss-Prot P26368 (U2AF2_HUMAN)

Last modified November 25, 2008. Version 105. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (4) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Alternative products · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Splicing factor U2AF 65 kDa subunit
Alternative name(s):
    U2 auxiliary factor 65 kDa subunit
      Short name=hU2AF65
      Short name=hU2AF(65)
    U2 snRNP auxiliary factor large subunit
Gene names
Name: U2AF2
Synonyms: U2AF65
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length475 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is further processed into a mature form.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

Necessary for the splicing of pre-mRNA. Binds to the polypyrimidine tract of introns early during spliceosome assembly. Required for the export of mRNA out of the nucleus, even if the mRNA is encoded by an intron-less gene.

Subunit structure

Interacts with U2AF1L4 By similarity. Heterodimer with U2AF1. Binds unphosphorylated SF1. Interacts with SFRS2IP.

Subcellular location

Nucleus.

Sequence similarities

Belongs to the splicing factor SR family.

Contains 3 RRM (RNA recognition motif) domains.

Ontologies

Keywords

   Biological processmRNA processing
mRNA splicing
   Cellular componentNucleus
Spliceosome
   Coding sequence diversityAlternative splicing
   DomainRepeat
   LigandRNA-binding
   PTMAcetylation
Phosphoprotein
   Technical term3D-structure
Direct protein sequencing

Gene Ontology (GO)

   Biological processnuclear mRNA splicing, via spliceosome

Inferred by curator. Source: HGNC

   Cellular componentspliceosome

Inferred from direct assay. Source: HGNC

   Molecular functionRNA binding

Inferred from electronic annotation. Source: InterPro

nucleotide binding

Inferred from electronic annotation. Source: InterPro

protein binding Ref.6 Ref.16

Inferred from physical interaction. Source: UniProtKB

Complete GO annotation...

Alternative products

This entry describes 2 isoforms produced by alternative splicing. [Align] [Select]
Isoform 1 (identifier: P26368-1)

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform 2 (identifier: P26368-2)

The sequence of this isoform differs from the canonical sequence as follows:
     345-348: Missing.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Initiator methionine11Removed
Chain2 – 475474Splicing factor U2AF 65 kDa subunit
PRO_0000081988

Regions

Domain149 – 23183RRM 1
Domain259 – 33779RRM 2
Domain385 – 46682RRM 3
Compositional bias27 – 6236Arg/Ser-rich (RS domain)

Amino acid modifications

Modified residue21N-acetylserine
Modified residue21Phosphoserine
Modified residue531Phosphoserine
Modified residue551Phosphoserine
Modified residue791Phosphoserine

Natural variations

Alternative sequence345 – 3484Missing in isoform 2.
VSP_035414

Experimental info

Mutagenesis921W → A: Decreases affinity for UAF1 by 3 orders of magnitude
Mutagenesis961P → G: Decreases affinity for UAF1 by 2 orders of magnitude
Mutagenesis1041P → G: Decreases affinity for UAF1 by 2 orders of magnitude
Mutagenesis387 – 3882EE → RR: Reduces interaction with SF1
Mutagenesis391 – 3944DDEE → AAAA: Reduces interaction with SF1
Mutagenesis391 – 3944DDEE → RRKK: Reduces interaction with SF1
Mutagenesis396 – 3972EE → AA: No effect
Mutagenesis396 – 3972EE → GA: Reduces interaction with SF1
Mutagenesis396 – 3972EE → KK: Reduces interaction with SF1
Mutagenesis4541F → A: Reduces interaction with SF1

Secondary structure

...................................................... 475
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
Isoform 1 [UniParc].

Last modified January 23, 2007. Version 4.
Checksum: 26AD271CD8FC6211

FASTA47553,501
        10         20         30         40         50         60 
MSDFDEFERQ LNENKQERDK ENRHRKRSHS RSRSRDRKRR SRSRDRRNRD QRSASRDRRR 

        70         80         90        100        110        120 
RSKPLTRGAK EEHGGLIRSP RHEKKKKVRK YWDVPPPGFE HITPMQYKAM QAAGQIPATA 

       130        140        150        160        170        180 
LLPTMTPDGL AVTPTPVPVV GSQMTRQARR LYVGNIPFGI TEEAMMDFFN AQMRLGGLTQ 

       190        200        210        220        230        240 
APGNPVLAVQ INQDKNFAFL EFRSVDETTQ AMAFDGIIFQ GQSLKIRRPH DYQPLPGMSE 

       250        260        270        280        290        300 
NPSVYVPGVV STVVPDSAHK LFIGGLPNYL NDDQVKELLT SFGPLKAFNL VKDSATGLSK 

       310        320        330        340        350        360 
GYAFCEYVDI NVTDQAIAGL NGMQLGDKKL LVQRASVGAK NATLVSPPST INQTPVTLQV 

       370        380        390        400        410        420 
PGLMSSQVQM GGHPTEVLCL MNMVLPEELL DDEEYEEIVE DVRDECSKYG LVKSIEIPRP 

       430        440        450        460        470 
VDGVEVPGCG KIFVEFTSVF DCQKAMQGLT GRKFANRVVV TKYCDPDSYH RRDFW 

« Hide

Isoform 2 [UniParc].

Checksum: 3F59A02CD2B03F46
Show »

47153,121

References

« Hide 'large scale' references
[1]"Cloning and domain structure of the mammalian splicing factor U2AF."
Zamore P.D., Patton J.G., Green M.R.
Nature 355:609-614(1992) [PubMed: 1538748] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
[2]Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. expand/collapse author list , Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W., Venter J.C.
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[3]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
Tissue: Lymph and Skin.
[4]Bienvenut W.V., Heiserich L., Boulahbel H., Gottlieb E.
Submitted (NOV-2006) to UniProtKB
Cited for: PROTEIN SEQUENCE OF 2-9; 196-203; 277-286 AND 463-471, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT SER-2, MASS SPECTROMETRY.
Tissue: Colon carcinoma.
[5]"Large-scale proteomic analysis of the human spliceosome."
Rappsilber J., Ryder U., Lamond A.I., Mann M.
Genome Res. 12:1231-1245(2002) [PubMed: 12176931] [Abstract]
Cited for: PROTEIN SEQUENCE OF 261-286, MASS SPECTROMETRY, INTERACTION WITH THE SPLICEOSOME.
[6]"Sip1, a novel RS domain-containing protein essential for pre-mRNA splicing."
Zhang W.-J., Wu J.Y.
Mol. Cell. Biol. 18:676-684(1998) [PubMed: 9447963] [Abstract]
Cited for: INTERACTION WITH SFRS2IP.
[7]"Phosphorylation of splicing factor SF1 on Ser20 by cGMP-dependent protein kinase regulates spliceosome assembly."
Wang X., Bruderer S., Rafi Z., Xue J., Milburn P.J., Kraemer A., Robinson P.J.
EMBO J. 18:4549-4559(1999) [PubMed: 10449420] [Abstract]
Cited for: INTERACTION WITH SF1.
[8]"Global phosphoproteome analysis on human HepG2 hepatocytes using reversed-phase diagonal LC."
Gevaert K., Staes A., Van Damme J., De Groot S., Hugelier K., Demol H., Martens L., Goethals M., Vandekerckhove J.
Proteomics 5:3589-3599(2005) [PubMed: 16097034] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2, MASS SPECTROMETRY.
Tissue: Hepatocyte.
[9]"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.
Cell 127:635-648(2006) [PubMed: 17081983] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-53; SER-55 AND SER-79, MASS SPECTROMETRY.
Tissue: Epithelium.
[10]"Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.
J. Proteome Res. 6:4150-4162(2007) [PubMed: 17924679] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-79, MASS SPECTROMETRY.
Tissue: Epithelium.
[11]"Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry."
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007) [PubMed: 17287340] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-79, MASS SPECTROMETRY.
[12]"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.
Anal. Sci. 24:161-166(2008) [PubMed: 18187866] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-79, MASS SPECTROMETRY.
[13]"Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis."
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III
J. Proteome Res. 7:1346-1351(2008) [PubMed: 18220336] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-79, MASS SPECTROMETRY.
[14]"Solution structures of the first and second RNA-binding domains of human U2 small nuclear ribonucleoprotein particle auxiliary factor (U2AF(65))."
Ito T., Muto Y., Green M.R., Yokoyama S.
EMBO J. 18:4523-4534(1999) [PubMed: 10449418] [Abstract]
Cited for: STRUCTURE BY NMR OF 148-237.
[15]"Structural basis for the molecular recognition between human splicing factors U2AF65 and SF1/mBBP."
Selenko P., Gregorovic G., Sprangers R., Stier G., Rhani Z., Kraemer A., Sattler M.
Mol. Cell 11:965-976(2003) [PubMed: 12718882] [Abstract]
Cited for: STRUCTURE BY NMR OF 372-475 IN COMPLEX WITH SF1, MUTAGENESIS OF 387-GLU-GLU-388; 391-ASP--GLU-393; 396-GLU-GLU-397 AND PHE-454.
[16]"A novel peptide recognition mode revealed by the X-ray structure of a core U2AF35/U2AF65 heterodimer."
Kielkopf C.L., Rodionova N.A., Green M.R., Burley S.K.
Cell 106:595-605(2001) [PubMed: 11551507] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 90-112 IN COMPLEX WITH U2AF1, MUTAGENESIS OF TRP-92; PRO-96 AND PRO-104.
+Additional computationally mapped references.

Cross-references

Sequence databases

X64044 mRNA. Translation: CAA45409.1.
CH471135 Genomic DNA. Translation: EAW72404.1.
BC008740 mRNA. Translation: AAH08740.1.
BC030574 mRNA. Translation: AAH30574.1.
PIRS20250.
RefSeqNP_001012496.1.
NP_009210.1.
UniGeneHs.528007

3D structure databases

EntryMethodResolution (Å)ChainPositionsPDBsum
1JMTX-ray2.20B85-112[»]
1O0PNMR-A372-475[»]
1OPINMR-A372-475[»]
1U2FNMR-A148-237[»]
2G4BX-ray2.50A148-336[»]
2HZCX-ray1.47A148-229[»]
2U2FNMR-A258-342[»]
ModBaseSearch...

Protein-protein interaction databases

DIPDIP:2154N.

PTM databases

PhosphoSiteP26368.

Genome annotation databases

EnsemblENSG00000063244. Homo sapiens. [Contig view]
GeneID11338.